HSIS nutritionist Dr Carrie Ruxton said the study was an example of nutrients being asked to do that which they are not designed to do, or capable of doing.
“This latest review is yet another study that has attempted to use vitamin supplements in high doses as if they were drugs in a trial amongst patients who already had cardiovascular disease,” she said.
“Vitamin supplements are not intended for the treatment of chronic conditions such as cardiovascular disease and cancer. Supplements are for health maintenance and should be used to boost dietary levels of nutrients, an important role since we know that significant proportions of the UK population have lower than recommended vitamin intakes.”
Dr Ruxton’s comments echoed those of the US Council for Responsible Nutrition (CRN) reported in our coverage of the study and which can be found here.
Reduced homocysteine levels
She pointed out that while the study did not deliver benefits to the cardio-sick subjects, it did affirm the link between blood homocysteine levels and B vitamins. There were no side-effects despite the high dosage used in the trial.
“These patients were given high dose B vitamin supplements, higher than those generally available on sale to consumers in UK high streets,” she said.